Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy
Authors:
Open Access
- 6 February 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 75
Abstract
Combination therapy which enhances efficacy and reduces toxicity, has been increasingly applied as a promising strategy for cancer therapy. Here, a reactive oxygen species (ROS) that enhanced combination chemotherapy nanodevices was fabricated based on the Fe-chelated polydopamine (PDA) nanoparticles (NPs). The structure was characterized by dynamic light scattering-autosizer, transmission electron microscopy, energy dispersive spectroscopy, and Fourier-transform infrared (FT-IR) spectrophotometer. The in vitro drug release profile triggered by low intracellular pH indicated that the system demonstrated controlled therapeutic activity. In vitro cell uptake studies showed that doxorubicin (DOX)-loaded Fe-PDA/ folic acid (FA)- polyethylene glycol (DOX@Fe-PDA/FA-PEG) had a strong uptake capacity and can be rapidly internalized by MCF-7 cells. The in vitro experiments demonstrated that DOX@Fe-PDA/FA-PEG triggered the intracellular ROS overproduction, thereby enhancing its therapeutic effect on breast cancer. In summary, this experiment demonstrated the novel DOX-loaded composite NPs used as a potential targeted nanocarrier for breast cancer treatment, which could be a promising therapeutic strategy against breast cancer.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 39 references indexed in Scilit:
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneityAdvanced Drug Delivery Reviews, 2015
- Intrinsically Mn2+-Chelated Polydopamine Nanoparticles for Simultaneous Magnetic Resonance Imaging and Photothermal Ablation of Cancer CellsACS Applied Materials & Interfaces, 2015
- Cancer nanomedicine: from targeted delivery to combination therapyTrends in Molecular Medicine, 2015
- Reactive Oxygen Species in Cancer: A Dance with the DevilCancer Cell, 2015
- New Insight into the Role of Reactive Oxygen Species (ROS) in Cellular Signal-Transduction Processes2015
- Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical FieldsChemical Reviews, 2014
- The role of iron and reactive oxygen species in cell deathNature Chemical Biology, 2013
- Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian CancerPLOS ONE, 2012
- Amelioration of Doxorubicin-Induced Cardiotoxicity by an Anticancer-Antioxidant Dual-Function Compound, HO-3867The Journal of Pharmacology and Experimental Therapeutics, 2011
- Physical and chemical stability of drug nanoparticlesAdvanced Drug Delivery Reviews, 2011